Investment Thesis

Biotech and technology first. Founder quality always.

Asheya Ventures looks for early evidence of unusual insight, technical depth, market urgency, and founders who can learn faster than the market.

BIO

Biotech & Translational Science

Platforms and products with credible science, clear development paths, and founder teams who understand both research and commercialization.

TECH

Software, AI & Data

Products that turn complexity into workflows, leverage data advantage, or create measurable business outcomes.

X

Exceptional Outliers

Selective investments outside core categories when the market, founder, and timing create a compelling asymmetry.

Evaluation Criteria

What matters in the first conversation.

Team

Founder-market fit, technical depth, coachability, resilience, and speed of learning.

Problem

A painful need with a buyer, user, or scientific stakeholder who has urgency.

Evidence

Early data, pilots, publications, prototypes, customer demand, or technical milestones.

Market

Large or rapidly changing markets where early entry can create durable advantage.